{
  "cik": 1447028,
  "cik_padded": "0001447028",
  "entityName": "Arbutus Biopharma Corp",
  "fiscal_years": [
    {
      "accn": "0001447028-26-000017",
      "filed": "2026-03-23",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 0.0,
        "cash": 18008000.0,
        "eps_diluted": -0.17,
        "free_cash_flow": -39637000.0,
        "net_income": -33501000.0,
        "operating_cash_flow": -39637000.0,
        "operating_income": -38160000.0,
        "revenue": 14083000.0,
        "stockholders_equity": 76576000.0,
        "total_assets": 94618000.0,
        "total_liabilities": 18042000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.23560906811533638,
        "revenue_growth_yoy": 1.2821260735699238,
        "roa_avg2y": -0.29604330056334915,
        "roa_period_end": -0.3540658225707582,
        "roe_avg2y": -0.3851973646387876,
        "roe_period_end": -0.43748694107814456
      }
    },
    {
      "accn": "0001447028-26-000017",
      "filed": "2026-03-23",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 182000.0,
        "cash": 36330000.0,
        "eps_diluted": -0.38,
        "free_cash_flow": -65032000.0,
        "net_income": -69920000.0,
        "operating_cash_flow": -64850000.0,
        "operating_income": -76319000.0,
        "revenue": 6171000.0,
        "stockholders_equity": 97366000.0,
        "total_assets": 131707000.0,
        "total_liabilities": 34341000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3527001211922026,
        "revenue_growth_yoy": -0.6598313213163552,
        "roa_avg2y": -0.506468483347096,
        "roa_period_end": -0.5308753521073292,
        "roe_avg2y": -0.6875663769028045,
        "roe_period_end": -0.7181151531335374
      }
    },
    {
      "accn": "0001447028-26-000017",
      "filed": "2026-03-23",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1008000.0,
        "cash": 26285000.0,
        "eps_diluted": -0.44,
        "free_cash_flow": -86944000.0,
        "net_income": -72849000.0,
        "operating_cash_flow": -85936000.0,
        "operating_income": -78103000.0,
        "revenue": 18141000.0,
        "stockholders_equity": 106018000.0,
        "total_assets": 144401000.0,
        "total_liabilities": 38383000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3620422947046728,
        "revenue_growth_yoy": -0.5350726569107358,
        "roa_avg2y": -0.428750514978518,
        "roa_period_end": -0.5044909661290434,
        "roe_avg2y": -0.5999011817021451,
        "roe_period_end": -0.6871380331641797
      }
    },
    {
      "accn": "0001447028-25-000083",
      "filed": "2025-03-27",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 512000.0,
        "cash": 30776000.0,
        "eps_diluted": -0.46,
        "free_cash_flow": -35868000.0,
        "net_income": -69456000.0,
        "operating_cash_flow": -35356000.0,
        "operating_income": -65456000.0,
        "revenue": 39019000.0,
        "stockholders_equity": 136852000.0,
        "total_assets": 195419000.0,
        "total_liabilities": 58567000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4279586706807354,
        "revenue_growth_yoy": 2.5510556971241356,
        "roa_avg2y": -0.34736336720812994,
        "roa_period_end": -0.35542091608287835,
        "roe_avg2y": -0.45352948666464243,
        "roe_period_end": -0.5075263788618362
      }
    },
    {
      "accn": "0001447028-24-000035",
      "filed": "2024-03-05",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 809000.0,
        "cash": 109282000.0,
        "eps_diluted": -0.83,
        "free_cash_flow": -68341000.0,
        "net_income": -76247000.0,
        "operating_cash_flow": -67532000.0,
        "operating_income": -73522000.0,
        "revenue": 10988000.0,
        "stockholders_equity": 169439000.0,
        "total_assets": 204485000.0,
        "total_liabilities": 35046000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.20683549832092965,
        "revenue_growth_yoy": 0.5892392247613538,
        "roa_avg2y": -0.4464567505452842,
        "roa_period_end": -0.3728733158911412,
        "roe_avg2y": -0.5618687938689413,
        "roe_period_end": -0.4499967539940627
      }
    },
    {
      "accn": "0001447028-23-000018",
      "filed": "2023-03-02",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 229000.0,
        "cash": 52251000.0,
        "eps_diluted": -1.0,
        "free_cash_flow": -51670000.0,
        "net_income": -63745000.0,
        "operating_cash_flow": -51441000.0,
        "operating_income": -57806000.0,
        "revenue": 6914000.0,
        "stockholders_equity": 101966000.0,
        "total_assets": 137080000.0,
        "total_liabilities": 35114000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3443696918580703,
        "revenue_growth_yoy": 0.1502245882548661,
        "roa_avg2y": -0.5254827607526328,
        "roa_period_end": -0.46502042602859645,
        "roe_avg2y": -0.7297235418693836,
        "roe_period_end": -0.6251593668477727
      }
    },
    {
      "accn": "0001447028-22-000019",
      "filed": "2022-03-03",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 589000.0,
        "cash": 31799000.0,
        "free_cash_flow": -71595000.0,
        "net_income": -153723000.0,
        "operating_cash_flow": -71006000.0,
        "operating_income": -143901000.0,
        "revenue": 6011000.0,
        "stockholders_equity": 72744000.0,
        "total_assets": 105535000.0,
        "total_liabilities": 32791000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4507725723083691,
        "revenue_growth_yoy": 0.011101766190075694,
        "roa_avg2y": -0.9220429462571977,
        "roa_period_end": -1.456606812905671,
        "roe_avg2y": -1.1262665855856515,
        "roe_period_end": -2.1132052128010557
      }
    },
    {
      "accn": "0001447028-21-000021",
      "filed": "2021-03-04",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1138000.0,
        "cash": 36942000.0,
        "eps_diluted": -1.21,
        "free_cash_flow": -69004000.0,
        "net_income": -57060000.0,
        "operating_cash_flow": -67866000.0,
        "operating_income": -89780000.0,
        "revenue": 5945000.0,
        "stockholders_equity": 200234000.0,
        "total_assets": 227905000.0,
        "total_liabilities": 27671000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1381933138228273,
        "revenue_growth_yoy": -0.444392523364486,
        "roa_avg2y": -0.24538452606726788,
        "roa_period_end": -0.2503674776771023,
        "roe_avg2y": -0.29819156691672744,
        "roe_period_end": -0.28496658909076383
      }
    },
    {
      "accn": "0001447028-20-000038",
      "filed": "2020-03-05",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7264000.0,
        "cash": 54292000.0,
        "eps_diluted": -1.56,
        "free_cash_flow": -55904000.0,
        "net_income": -84413000.0,
        "operating_cash_flow": -48640000.0,
        "operating_income": -110930000.0,
        "revenue": 10700000.0,
        "stockholders_equity": 182473000.0,
        "total_assets": 237161000.0,
        "total_liabilities": 54688000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.29970461383327945,
        "revenue_growth_yoy": 6.176391683433937,
        "roa_avg2y": -0.3290442036329617,
        "roa_period_end": -0.35593120285375757,
        "roe_avg2y": -0.4379653313548374,
        "roe_period_end": -0.46260542655625764
      }
    },
    {
      "accn": "0001628280-18-003276",
      "filed": "2019-03-07",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3996000.0,
        "cash": 23413000.0,
        "eps_diluted": -7.24,
        "free_cash_flow": -61881000.0,
        "net_income": -384164000.0,
        "operating_cash_flow": -57885000.0,
        "operating_income": -491639000.0,
        "revenue": 1491000.0,
        "stockholders_equity": 203005000.0,
        "total_assets": 275919000.0,
        "total_liabilities": 72914000.0
      },
      "period_end": "2016-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.35917341937390707,
        "roa_period_end": -1.3923071626093164,
        "roe_period_end": -1.8923868870224871
      }
    },
    {
      "accn": "0001628280-18-003276",
      "filed": "2018-03-16",
      "fiscal_year": 2015,
      "form": "10-K",
      "fundamental_units": {
        "eps_diluted": "USD/shares"
      },
      "fundamentals": {
        "eps_diluted": -1.38
      },
      "period_end": "2015-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001447028-26-000017",
    "filed": "2026-03-23",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001447028.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001447028.json"
  },
  "ticker": "ABUS"
}
